Mark Diamond
Chairman chez DIMERIX LIMITED
Fortune : 264 995 $ au 31/03/2024
Provenance du réseau au premier degré de Mark Diamond
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Diamond via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| RESMED, INC. | Medical Specialties | Director/Board Member | |
| HELIX BIOMEDIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| GENETIC TECHNOLOGIES LIMITED | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| KAZIA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| CSL LIMITED | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| THE SUSTAINABLE NUTRITION GROUP LTD | Agricultural Commodities/Milling | Corporate Officer/Principal | |
| AVECHO BIOTECHNOLOGY LIMITED | Pharmaceuticals: Major | Chief Operating Officer | |
| Melbourne Business School | College/University | Masters Business Admin | |
| ASX LIMITED | Investment Banks/Brokers | Corporate Officer/Principal | |
| TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALTERITY THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Director of Finance/CFO | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The private company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Pharmaceuticals: Other | Chairman | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Masters Business Admin Undergraduate Degree | |
| ACRUX LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree | |
| IMMURON LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO | |
| University of Rio Grande | College/University | Undergraduate Degree | |
| The University of Queensland | College/University | Corporate Officer/Principal Graduate Degree | |
| University College London | College/University | Undergraduate Degree | |
| RMIT University | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| SIGMA HEALTHCARE LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Cardiff | College/University | Doctorate Degree | |
| LaTrobe University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Santiago de Compostela | College/University | Doctorate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BMG Pharma LLC | Chairman | ||
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Chief Executive Officer | |
Afandin Pty Ltd.
 Afandin Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Afandin Pty Ltd. operates as a corporate advisory company. The firm’s services include operational support, corporate development strategic support, product development strategic support, finance and international referral network. The company was founded by Ian Thomas Nisbet and Anthony Filippis and is headquartered in Camberwell, Australia. | Miscellaneous Commercial Services | Founder | |
Neurosciences Victoria Ltd.
 Neurosciences Victoria Ltd. Medical SpecialtiesHealth Technology Neurosciences Victoria Ltd. offers an access point to a series of neuroscience technology-based platforms. The company was founded in 2001 and is headquartered in Melbourne, Australia. | Medical Specialties | Chief Executive Officer | |
| MAYNE PHARMA GROUP LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Kendle Pty Ltd. | Corporate Officer/Principal | ||
| BMG Hematology LLC | Chief Executive Officer | ||
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Takeda Pharmaceuticals Australia Pty Ltd. | Chief Tech/Sci/R&D Officer | ||
| Linear Clinical Research Ltd. | Director/Board Member | ||
KCBN Holding, Inc.
 KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Miscellaneous | Chief Tech/Sci/R&D Officer | |
| Metrodora Therapeutics, Inc. | Chairman | ||
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Biotechnology | Chairman | |
Kinoxis Therapeutics Pty Ltd.
 Kinoxis Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Kinoxis Therapeutics Pty Ltd. engages in conducting biotechnology research. The company is headquartered in Camberwell, Australia. | Miscellaneous Commercial Services | Chief Executive Officer | |
Eflare Corp. Pty Ltd.
 Eflare Corp. Pty Ltd. Wholesale DistributorsDistribution Services Part of Wescom Signal & Rescue UK Ltd., Eflare Corp. Pty Ltd. is an Australian company that wholesales electronic safety devices. The private company is based in Clayton, Australia. The company was founded in 1994. The CEO is Glen Sharkie. Eflare was acquired by Wescom Signal & Rescue UK Ltd. on February 06, 2024. | Wholesale Distributors | Director/Board Member | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| Assayquant Technologies, Inc. | Director/Board Member | ||
Servatus Ltd.
 Servatus Ltd. Pharmaceuticals: MajorHealth Technology Servatus Ltd. is an Australian private company located in Coolum Beach. The firm manufactures medical-grade biopharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
| Lassen Therapeutics 1 Pty Ltd. | Director/Board Member |
Statistiques
Internationale
| Australie | 34 |
| Etats-Unis | 15 |
| Royaume-Uni | 3 |
| Espagne | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 70 |
| Corporate Secretary | 42 |
| Corporate Officer/Principal | 38 |
| Director of Finance/CFO | 24 |
| Independent Dir/Board Member | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Phillip Hains | 43 |
| Gary Pace | 32 |
| Ben Price | 13 |
| Hugh Alsop | 13 |
| Robert William Moses | 11 |
| William Goolsbee | 9 |
| Nuket Desem | 8 |
| C. Bennett | 8 |
| James Garner | 7 |
| Anthony Filippis | 7 |
| Nina Webster | 7 |
| Sonia Maria Poli | 7 |
| Hamish George | 5 |
| Kathryn Andrews | 5 |
| Christopher Wraight | 5 |
- Bourse
- Insiders
- Mark Diamond
- Connexions Sociétés
